Company intelligence / Profile preview

BioProtect

Kochav Yair Tzur Yigal, Center District, Israelbioprotect.com ↗

Ownership: Private
Development stage: Commercial

Overview

BioProtect has developed a proprietary bioabsorbable polymer balloon implant system that creates space between the prostate and rectum to protect healthy tissue during high-dose prostate radiotherapy. Clinical data show significant reduction in rectal toxicity and improved safety profile. The device absorbs within six months post-procedure. Ongoing FDA trials are underway to support broader commercialization.

Therapeutic areas: Oncology
Modalities: Device (specifically biodegradable balloon implant)Biodegradable polymer technology
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on BioProtect.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioProtect.

Explore the full profile